ALBERT DACOSTA is one of the founders, President & Chief Executive Officer of Paragon 28, Inc. a private Medical Device company focusing exclusively on Foot and Ankle ailments. Albert has worked toward the goal of redefining the emerging F&A segment through research, innovation and quality to better the surgical outcomes for patients. A Chemical Engineering graduate from the University of Florida with a minor in Business, Albert previously worked with Wright Medical, Inc. as their Corporate Director of Biologics and Extremities until founding Paragon 28, Inc. in late 2010. The company is expecting to enter the EMEA market in mid 2016 with a vision of a more globally based exchange of best practices and learning. In addition, this year will signal the launch of the humanitarian division of P28 with a goal to provide implants, instruments and training for global surgical charities. Albert has worked with some of the world’s most renowned Foot & Ankle surgeons and is considered one of the most forward thinking industry champions.